XML 37 R26.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 3 - Collaborative and Other Research and Development Contracts (Details Textual) - USD ($)
$ in Thousands
1 Months Ended 6 Months Ended 39 Months Ended
Jun. 16, 2015
Feb. 28, 2006
Sep. 30, 2013
Jun. 30, 2006
Jun. 30, 2000
Jun. 30, 2018
Jun. 30, 2018
Mar. 31, 2015
CSL Limited [Member                
Proceeds from License Fees Received $ 33,740              
Milestone Payment Received 7,000              
Milestone Payment Maximum $ 5,000              
Royalty Term 10 years              
National Institute of Allergy and Infectious Diseases [Member]                
Collaborative Agreement Contract Value     $ 5,000          
Expected Receivable From Awards for Research and Development Contracts           $ 39,477    
UAB [Member]                
Period of Agreement           25 years    
Renewable Period of Agreement           5 years    
Base Contract [Member]                
Government Contract Receivable               $ 16,265
Additional Development Options [Member]                
Government Contract Receivable               22,855
ASPRBARDA Contract [Member]                
Government Contract Receivable               $ 39,120
Proceeds from awards for Research and Development Contracts             $ 20,574  
Green Cross Corporation [Member]                
Proceeds from License Fees Received       $ 250        
Mundipharma [Member]                
Upfront Payments Receivable Amount   $ 10,000            
AECOM and IRL [Member]                
Milestone Payment Maximum         $ 4,000      
Milestone Payment Minimum         1,400      
Annual License Fee Minimum         150      
Annual License Fee Maximum         $ 500      
Advance Notice Period for Termination of Agreement         60 days